|
|
Harbin Pharmaceutical Group Co Ltd A
SHSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/14/2026 15:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization9,343.67 mln
Float1,312 mln
Key Fundamentals
EPS0.12
P/E34.00
ROE5.46
RPS6.18
ROIC8.75
ROA2.18
Interest Cover16.99
EBITDA, mln548
EV / EBITDA11.13
EV / EBIT11.13
Revenue, mln15,965
EV / Revenue0.38
Financial Strength
Altman Z-Score2.35
Piotroski F-Score
5
/ 9
Beneish M-Score-2.58
Price to Intrinsic Value1.53
Price to Graham Number1.38
Shiller PE Ratio30.91
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
32.9% |
100
/ 100
 |
| 1 Month |
29.11% |
97
/ 100
 |
| 2 Months |
13.33% |
81
/ 100
 |
| 6 Months |
18.26% |
81
/ 100
|
| 1 Year |
10.87% |
60
/ 100
 |
|
| |
